Li, H., Geng, C., Zhao, H., Jiang, H., Song, G., Zhang, J., . . . Liang, X. (2021). Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis. Chin J Cancer Res.
Style de citation ChicagoLi, Huiping, et al. "Multicenter Phase II Study of Apatinib Single or Combination Therapy in HER2-negative Breast Cancer Involving Chest Wall Metastasis." Chin J Cancer Res 2021.
Style de citation MLALi, Huiping, et al. "Multicenter Phase II Study of Apatinib Single or Combination Therapy in HER2-negative Breast Cancer Involving Chest Wall Metastasis." Chin J Cancer Res 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.